Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Post by stanleyon Aug 11, 2012 5:07pm
486 Views
Post# 20207809

Ore Reserve & PEA Announcements

Ore Reserve & PEA Announcements

RE:"Planning is under way to develop the Grey Fox mine, located on the southeast portion of the Black Fox complex. The initial resource estimate from this area, announced in December, 2011, added more than 50 per cent to the gold resource at the Black Fox complex. Brigus is in the process of expanding the resource and converting inferred ounces to indicated ounces through systematic infill drilling. An updated resource estimate will be released in September. Initial engineering studies have also been initiated and will continue through 2012 to determine project economics as well as development and production timelines. A preliminary economic assessment (PEA) for Grey Fox will be released in the fourth quarter, and will incorporate the new resource."

 

[S]  Two key dates going foward. Look at Lakeshore and Timmins for options of how to take BRD to the second pearl (in the string). Alternatively a JV with a deep pocketed major or Matheson/Hislop player with access to milling capacity.. might just be the ticket.  In addition, the switch of mining methods to (banked tonnage) longhole, will present BRD with an opportunity to carry a drilled reserve and limit blasting to an as needed status. But first this "drilled reserve" will have to be drilled and the blast and mucking will also have to be defined. Once established the flexibility will only be positive.

 

 

BWDIK? It all takes time! Sequencing is not the answer for the impatient. Bulk (jumbo) mining is cheap but longhole may be as cheap; but the time taken to establish the "drilled reserve" is way different.

 

Cheers

Stanley

Bullboard Posts